Sentinel node biopsy for the staging of breast cancer
HAYES, Inc.
Record ID 32006000943
English
Authors' objectives:
Sentinel node biopsy (SNB) is a cancer staging technique in which the first lymph node(s) to receive lymph from the primary tumor, the sentinel node(s), is removed and examined histologically for tumor cells. The use of SNB for staging breast cancer is based on the assumption that if the first lymph node in the axillary chain is negative for tumor cells, then the remaining nodes will also be negative, and complete axillary lymph node dissection (ALND) is unnecessary. In this way, the morbidity associated with complete ALND would be avoided in patients with negative axillary nodes. Patients who are diagnosed with a positive SNB undergo standard lymphadenectomy to determine the extent of lymph node involvement.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=2329
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Sentinel Lymph Node Biopsy
- Breast Neoplasms
- Lymphatic Metastasis
- Neoplasm Staging
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.